menu
    • menu

    Company profile for NeuroSigma

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD. NeuroSigma is researching t...
    NeuroSigma is a California-based life sciences company established to develop bioelectronic technologies with the potential to transform medical practice and patients' lives. NeuroSigma is focused on TNS neuromodulation therapies based on intellectual property, licensed on an exclusive basis from the University of California, Los Angeles (UCLA), covering a wide-spectrum of disorders, including ADHD. NeuroSigma is researching trigeminal nerve stimulation (TNS) as a novel neuromodulation therapy for a variety of neurological and neuropsychiatric disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroSigmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    10960 Wilshire Blvd., Suite 1910 Los Angeles, CA 90024
    Telephone
    Telephone
    310-479-3100
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.neurosigma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Neurosigma Invests $1M In Manufacturing For Monarch eTNS Device
    Neurosigma Invests $1M In Manufacturing For Monarch eTNS Device

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205355/0/en/NeuroSigma-Completes-1-Million-Investment-into-High-Volume-Manufacturing-Line-for-Second-Generation-Monarch-eTNS-Device.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    NeuroSigma Launches Monarch for Pediatric ADHD After Pilot Study
    NeuroSigma Launches Monarch for Pediatric ADHD After Pilot Study

    18 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/18/3190286/0/en/NeuroSigma-Launches-Next-Generation-Monarch-Device-for-Pediatric-ADHD-After-Successful-Pilot-Program.html

    GLOBENEWSWIRE
    18 Nov 2025
    Share Share
    Neurosigma Reveals Real-Time Brain Activity Effects Of eTNS
    Neurosigma Reveals Real-Time Brain Activity Effects Of eTNS

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179541/0/en/NeuroSigma-Announces-New-Publication-Showing-Real-Time-Effects-of-External-Trigeminal-Nerve-Stimulation-eTNS-on-Brain-Activity.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    NeuroSigma Gets Patent Allowance for Monarch eTNS System in China
    NeuroSigma Gets Patent Allowance for Monarch eTNS System in China

    10 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/10/3096682/0/en/NeuroSigma-Announces-Notice-of-Allowance-for-Patent-Protecting-Monarch-eTNS-System-in-China.html

    GLOBENEWSWIRE
    10 Jun 2025
    Share Share
    NeuroSigma Announces New Clinical Trial of Monarch eTNS System
    NeuroSigma Announces New Clinical Trial of Monarch eTNS System

    30 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/30/3071540/0/en/NeuroSigma-Announces-New-Clinical-Trial-of-Monarch-eTNS-System-for-Treatment-of-ADHD-in-Children-with-Fetal-Alcohol-Syndrome-at-UCLA.html

    GLOBENEWSWIRE
    30 Apr 2025
    Share Share
    NeuroSigma Patent Protects Trigeminal Nerve Use For Dyslexia
    NeuroSigma Patent Protects Trigeminal Nerve Use For Dyslexia

    22 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/22/3013551/0/en/NeuroSigma-Announces-Patent-Application-Protecting-Use-of-Trigeminal-Nerve-Stimulation-to-Include-Treatment-of-Dyslexia-and-Other-Neurodevelopmental-Disorders.html

    GLOBENEWSWIRE
    22 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search